Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Two polyclonal antisera detect different AGE epitopes in human plasma samples.

Angela Maria Buongiorno1, E Sagratella, S Morelli

  • 1Clinical Biochemistry Laboratory, National Institute of Health, Viale Regina Elena, 299, 00161, Rome, Italy. angela.buongiorno@iss.it

Immunology Letters
|March 29, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deep Brain Stimulation for Cerebellar Ataxia: A Systematic Review on Indications, Targets and Outcomes.

Cerebellum (London, England)·2026
Same author

Activity standardization and determination of nuclear decay data of <sup>212</sup>Pb at LNE-LNHB and first measurements in the SIR at BIPM.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2025
Same author

The role of opicapone in the management of Parkinson's disease: an Italian consensus through a combined Nominal Group Technique and Delphi approach.

European review for medical and pharmacological sciences·2023
Same author

COVID-19 vaccine and autoimmune diabetes in adults: report of two cases.

Journal of endocrinological investigation·2022
Same author

[Gender Diversity and Impact on Work and Life Expectancy in Health Care. Results of a Survey Conducted in the Tuscany Region].

Igiene e sanita pubblica·2021
Same author

Human cell-based anti-inflammatory effects of rosiglitazone.

Journal of endocrinological investigation·2021
Same journal

Interleukin-6: A Potential Link in the Pathophysiology of Restless Legs Syndrome.

Immunology letters·2026
Same journal

The dendritic cell identity crisis: why conflicting classifications demand a consensus framework?

Immunology letters·2026
Same journal

The malignancy within: what cancer teaches us about human bonds.

Immunology letters·2026
Same journal

Progranulin enhances complement component 5a-primed neutrophil activation in antineutrophil cytoplasmic antibody-associated vasculitis.

Immunology letters·2026
Same journal

The newly identified role of TRIM72, an E3 ligase, in NINJ1-mediated plasma membrane rupture: focus on its anti-inflammatory function.

Immunology letters·2026
Same journal

The subsets of circulating follicular helper T cells play an important role in the pathogenesis of Autoimmune thyroid diseases.

Immunology letters·2026
See all related articles

Advanced glycation end products (AGEs) are higher in diabetic patients. Different antibodies detect varying AGE levels, indicating diverse AGE epitopes exist in health and disease.

Area of Science:

  • Biochemistry
  • Immunology
  • Diabetology

Background:

  • Advanced glycation end products (AGEs) are implicated in diabetic complications.
  • AGEs represent a diverse group of chemical structures with potentially distinct immunogenic properties.

Purpose of the Study:

  • To measure and compare AGE levels in normal and diabetic plasma using two distinct polyclonal antisera.
  • To investigate the epitope specificity of the antisera against different AGE structures.

Main Methods:

  • Enzyme-linked immunosorbent assay (ELISA) was employed to quantify AGE levels.
  • Two polyclonal antisera (CF5 and CF199) were used, raised with different immunogens and techniques.
  • Antisera reactivity was assessed after pre-incubation with AGE-bovine serum albumin (BSA) and carboxy-methyl-lysine-BSA.

Related Experiment Videos

Main Results:

  • AGE levels were significantly elevated in diabetic plasma compared to normal plasma (P<0.0001) for both antisera.
  • Antiserum CF199 consistently detected higher AGE levels than CF5 in both normal and diabetic samples (P<0.0001 and P<0.005, respectively).
  • CF5 showed significantly reduced reactivity to oxidation-derived AGEs and non-oxidative glucose-derived AGEs, suggesting specific epitope recognition.

Conclusions:

  • The findings highlight that a single antiserum may not capture the full spectrum of AGE epitopes present in biological samples.
  • Different AGE structures possess unique immunogenic characteristics, necessitating the use of multiple antibodies for comprehensive AGE assessment.
  • Understanding AGE heterogeneity is crucial for accurate diagnosis and management of diabetic complications.